Bile Duct Cancer Market to Grow by $1.07 Billion During 2026-2030: Key Trends, Investment Opportunities and Competitive Strategies Analyzed [Yahoo! Finance]
AbbVie Inc. (ABBV)
Last abbvie inc. earnings: 5/1 07:43 am
Check Earnings Report
US:NYSE Investor Relations:
investors.abbvie.com/investor-overview
Company Research
Source: Yahoo! Finance
Dublin, March 30, 2026 (GLOBE NEWSWIRE) -- The "Bile Duct Cancer Market Report 2026" has been added to ResearchAndMarkets.com's offering. The bile duct cancer market is witnessing robust growth, expanding from $2.59 billion in 2025 to an anticipated $2.82 billion in 2026 at a compound annual growth rate (CAGR) of 8.7%. This growth is fueled by advancements in early diagnostics, a rising incidence of liver and bile duct disorders, and the expansion of oncology treatment centers. Additionally, the increasing use of chemotherapy regimens and growing awareness of rare cancers contribute to market momentum. Looking ahead, the bile duct cancer market is projected to reach $3.89 billion in 2030, with a CAGR of 8.4%. Factors driving this expansion include increased investment in precision oncology research, the rising adoption of immunotherapy treatments, and advancements in diagnostic screening programs. Innovations such as AI-assisted cancer diagnostics and personalized treatment pathw
Show less
Read more
Impact Snapshot
Event Time:
ABBV
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABBV alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABBV alerts
High impacting AbbVie Inc. news events
Weekly update
A roundup of the hottest topics
ABBV
News
- 2 Healthcare Dividend Stocks to Buy as the Tech-Heavy Nasdaq Dips Below Correction Territory [Yahoo! Finance]Yahoo! Finance
- 2 Healthcare Dividend Stocks to Buy as the Tech-Heavy Nasdaq Dips Below Correction Territory [Globe and Mail, The (Toronto, Canada)]Globe and Mail, The
- What You Need to Know Ahead of AbbVie's Earnings Release [Yahoo! Finance]Yahoo! Finance
- Assessing AbbVie (ABBV) Valuation After New Dermatology Data And FDA Label Update [Yahoo! Finance]Yahoo! Finance
- Allergan Aesthetics Announces Fourth Annual, All-Access CoolMonth with Deals on CoolSculpting® [Yahoo! Finance]Yahoo! Finance
ABBV
Earnings
- 2/4/26 - Miss
ABBV
Sec Filings
- 4/2/26 - Form 4
- 4/2/26 - Form 4
- 4/2/26 - Form 4
- ABBV's page on the SEC website